» Articles » PMID: 3293836

Organ Specificity of Tumor Metastasis: Role of Preferential Adhesion, Invasion and Growth of Malignant Cells at Specific Secondary Sites

Overview
Specialty Oncology
Date 1988 Jun 1
PMID 3293836
Citations 153
Authors
Affiliations
Soon will be listed here.
Abstract

The locations of distant secondary tumors in many clinical cancers and animal tumors are nonrandom, and their distributions cannot be explained by simple anatomical or mechanical hypotheses based on the simple lodgment or trapping of tumor cell emboli in the first capillary bed encountered. Evidence from certain experimental tumor systems supports Paget's 'seed and soil' hypothesis on the nonrandom distributions of metastases, in which the unique properties of particular tumor cells ('seeds') and the different characteristics of each organ microenvironment ('soil') collectively determine the organ preference of metastasis. Experimentally, differential tumor cell adhesion to organ-derived microvessel endothelial cells and organ parenchymal cells, differential invasion of basement membranes and organ tissues, and differential responses to organ-derived growth-stimulatory and -inhibitory factors all appear to be important determinants in explaining the organ preference of metastasis. Each tumor system may achieve organ specificity because of its own unique set of multiple metastasis-associated properties and responses to host microenvironments. As neoplasms progress to more highly malignant states multisite metastases are more likely and organ-specific metastases may be masked or circumvented owing to stochastic events, tumor cell diversification, host selection processes, and increased production of tumor autocrine molecules that may modulate adhesion, invasion, growth, and other properties important in metastasis. The importance of each of these properties, however, appears to vary considerably among different metastatic tumor systems. These and other tumor cell and host properties may eventually be used to predict and explain the unique metastatic distributions of certain human malignancies.

Citing Articles

Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers.

Pena-Romero A, Orenes-Pinero E Cancers (Basel). 2022; 14(7).

PMID: 35406451 PMC: 8996887. DOI: 10.3390/cancers14071681.


Chick Embryo Experimental Platform for Micrometastases Research in a 3D Tissue Engineering Model: Cancer Biology, Drug Development, and Nanotechnology Applications.

Guller A, Kuschnerus I, Rozova V, Nadort A, Yao Y, Khabir Z Biomedicines. 2021; 9(11).

PMID: 34829808 PMC: 8615510. DOI: 10.3390/biomedicines9111578.


Chick fetal organ spheroids as a model to study development and disease.

Dakhel S, Davies W, Joseph J, Tomar T, Remeseiro S, Gunhaga L BMC Mol Cell Biol. 2021; 22(1):37.

PMID: 34225662 PMC: 8256237. DOI: 10.1186/s12860-021-00374-6.


Site-specific metastasis: A cooperation between cancer cells and the metastatic microenvironment.

Izraely S, Witz I Int J Cancer. 2020; 148(6):1308-1322.

PMID: 32761606 PMC: 7891572. DOI: 10.1002/ijc.33247.


The expressions of autotaxin-lysophosphatidate signaling-related proteins in metastatic breast cancer.

Shim S, Shin E, Lee C, Koo J Int J Clin Exp Pathol. 2020; 12(8):2920-2930.

PMID: 31934128 PMC: 6949729.


References
1.
Updyke T, Nicolson G . Malignant melanoma cell lines selected in vitro for increased homotypic adhesion properties have increased experimental metastatic potential. Clin Exp Metastasis. 1986; 4(4):273-84. DOI: 10.1007/BF00133592. View

2.
Nicolson G, Dulski K . Organ specificity of metastatic tumor colonization is related to organ-selective growth properties of malignant cells. Int J Cancer. 1986; 38(2):289-94. DOI: 10.1002/ijc.2910380221. View

3.
TAO T, Burger M . Non-metastasising variants selected from metastasising melanoma cells. Nature. 1977; 270(5636):437-8. DOI: 10.1038/270437a0. View

4.
Pressman D . CERTAIN ASPECTS OF TISSUE-SPECIFIC ANTIGENS. Proc Can Cancer Conf. 1963; 5:363-76. View

5.
Liotta L, Mandler R, MURANO G, Katz D, Gordon R, Chiang P . Tumor cell autocrine motility factor. Proc Natl Acad Sci U S A. 1986; 83(10):3302-6. PMC: 323501. DOI: 10.1073/pnas.83.10.3302. View